Read More Pharma Industry News Sen-Jam’s SJP-002C gets FDA-ready CMC milestone as investors eye late-stage trial momentum Sen-Jam finalizes NDA-ready CMC deliverables for SJP-002C with KVK Tech and expands investor engagement, positioning for Phase 2b/3 trials. byPallavi MadhirajuSeptember 29, 2025